
Methylphenidate Hcl Tablets
Form: Extended-release (ER) tablets
Strength: 18 mg, 27 mg, 36 mg, 54 mg ER tablets
Reference Brands: Concerta
Category: Drugs Using Osmotic Pump Systems
Concerta® (methylphenidate HCl) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and MDR standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality Concerta formulations, supporting effective ADHD treatment worldwide in both healthcare and veterinary contexts.
Quick Response Guaranteed | Verified Suppliers
Back to ListingThe Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Prazosin Hcl Tablets
Strength: 1 mg, 2 mg, 5 mg,10 mg
Form: Extended-release (ER) tablets
Reference Brands: Alpress LP
View DetailsCarbamazepine Tablets
Strength: 200 mg, 300 mg, 400 mg
Form: Extended-release (XR) tablets
Reference Brands: Tegretol XR
View DetailsDoxazosin Mesylate Capsules
Strength: 4 mg, 8 mg, and 12 mg
Form: Extended-release (ER) capsules
Reference Brands: Cardura XL
View DetailsVerapamil Hcl Tablets
Strength: 240 mg once daily
Form: Sustained-release tablets
Reference Brands: Covera-HS®
View DetailsQuick Response Guaranteed | Verified Suppliers